What Do Top Manufacturers Say about the Future of Hubs?

If you’re a specialty pharmaceutical manufacturer preparing to launch a new therapy, establishing a patient program that supports the patient’s journey from end to end—from therapy initiation to positive health outcomes—is critical.  So much so, it may be the difference between success and failure for the program, and for the therapeutic benefit of your brand.  […]

Read More…

How to Engage Patients Throughout the Therapy Journey 

Taking specialty medication is not usually as easy as taking a once daily pill. Rather, many specialty products require careful patient focus on how they should be handled and administered properly. Even when patients are prescribed a daily oral specialty medication, many of those oral medications come with a toxicity profile, or even a food requirement that must be carefully understood. For some specialty medications, patients may need to arrange travel and overnight stays if they’re receiving treatment administered at a location that might not be nearby.  […]

Read More…

Analytics and Data Integration: Changing the Game for Digital Hubs

Supporting patients throughout the entire specialty therapy journey is essential to achieving positive health outcomes. More and more, data is what lies at the heart of this critical objective. As CareMetx’s latest report, The Evolving Landscape of Digital Hubs revealed, the ability to integrate data seamlessly, then analyze and report on it effectively is critical for manufacturers that rely on digital hubs to support their drug programs. […]

Read More…

What Do Pharmaceutical Manufacturers Most Need from a Digital Hub? Our Research Uncovers the Trends

CareMetx is committed to supporting the patient journey in a way that improves therapy adherence, persistence, and health outcomes. To inform this work, our team is always deeply interested in understanding what pharmaceutical manufacturers most need in a digital hub in order to achieve those objectives. So, we took a deep dive into this topic, conducting a comprehensive study involving one-on-one interviews and surveys with leading manufacturers.   […]

Read More…

The Psychology of Patient Engagement: Equipping Patients for a Successful Journey

To ensure patients can fully benefit from prescribed therapies, it’s critical to identify and address the barriers that impede their ability to access, afford, initiate, adhere to, and stay on treatment. The specialty treatment journey is a complex one, with many points along the way where these barriers can jeopardize the patient experience and health outcomes.   […]

Read More…

CareMetx Omnichannel Program Drives Initiation and Persistence for a Self-Injectable Rheumatology Biologic

This client, the manufacturer of a self-injected rheumatology biologic, partnered with CareMetx to equip healthcare providers (HCPs) to support patients throughout their journey. CareMetx developed an omnichannel one-to-one patient and HCP support program, driven by a single platform, with touchpoints targeted to key points like first fill and first injection. […]

Read More…

Case Study: CareMetx Boosts Adherence and Persistence for Oral Oncology Therapy by Addressing Patient Journey Barriers

This leading pharmaceutical manufacturer contracted with CareMetx for an integrated patient support program to boost adherence and persistence for an oral oncology medication. CareMetx mapped the patient journey specific to this indication, then developed personalized touchpoints along the way, guided by a barrier assessment that identified the obstacles most likely to impact a given patient. […]

Read More…

Video Session: The Data-driven, Patient-focused Hub

It’s a surprisingly common misconception that the patient experience relating to initiating specialty treatments is straightforward once a prescription has been ordered, and once approval has been received from the payer. The truth is, the hurdles patients must overcome to access and adhere to specialty medication are numerous and ongoing.   […]

Read More…